MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia

Sara C. Monroe, Stephanie Y. Jo, Daniel S. Sanders, Venkatesha Basrur, Kojo S. Elenitoba-Johnson, Robert K. Slany, Jay Hess

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: The aim of this study was to better understand how mixed lineage leukemia (MLL) fusion proteins deregulate the expression of genes critical for leukemia. Materials and Methods: The transforming domain of one of the most common MLL fusion partners, AF9, was immunopurified after expression in myeloblastic M1 cells, and associating proteins were identified by mass spectrometric analysis. Chromatin immunoprecipitation followed by quantitative polymerase chain reaction was used to determine how binding of associating proteins compare across Hoxa9 and Meis1 in cell lines with and without MLL fusion proteins and how binding is altered during gene down-regulation and differentiation. Results: Consistent with earlier purifications of ENL and AF4 from 293 cells, the 90 amino acid C-terminal domain of AF9 associates with many other MLL translocation partners including Enl, Af4, Laf4, Af5q31, Ell, and Af10. This complex, termed elongation assisting proteins (EAPs), also contains the RNA polymerase II C-terminal domain kinase Cdk9/Cyclin T1/T2 (pTEFb) and the histone H3 lysine 79 methyltransferase Dot1L. Myeloid cells transformed by MLL fusions show higher levels and a broader distribution of EAP components at genes critical for leukemia. Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented. Conclusions: The findings suggest that MLL fusion proteins deregulate genes critical for leukemia by excessive recruitment and impaired dissociation of EAP from target loci.

Original languageEnglish (US)
JournalExperimental Hematology
Volume39
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Myeloid-Lymphoid Leukemia Protein
Regulator Genes
Leukemia
Cyclin T
Proteins
Gene Components
RNA Polymerase III
RNA Polymerase II
Chromatin Immunoprecipitation
Methyltransferases
Myeloid Cells
Protein Binding
Histones
Genes
Lysine
Carrier Proteins
Phosphotransferases
Down-Regulation
Gene Expression
Amino Acids

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Hematology

Cite this

MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. / Monroe, Sara C.; Jo, Stephanie Y.; Sanders, Daniel S.; Basrur, Venkatesha; Elenitoba-Johnson, Kojo S.; Slany, Robert K.; Hess, Jay.

In: Experimental Hematology, Vol. 39, No. 1, 01.2011.

Research output: Contribution to journalArticle

Monroe, Sara C. ; Jo, Stephanie Y. ; Sanders, Daniel S. ; Basrur, Venkatesha ; Elenitoba-Johnson, Kojo S. ; Slany, Robert K. ; Hess, Jay. / MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. In: Experimental Hematology. 2011 ; Vol. 39, No. 1.
@article{6abf54b71c6c4748b6b73d349dec1c9f,
title = "MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia",
abstract = "Objective: The aim of this study was to better understand how mixed lineage leukemia (MLL) fusion proteins deregulate the expression of genes critical for leukemia. Materials and Methods: The transforming domain of one of the most common MLL fusion partners, AF9, was immunopurified after expression in myeloblastic M1 cells, and associating proteins were identified by mass spectrometric analysis. Chromatin immunoprecipitation followed by quantitative polymerase chain reaction was used to determine how binding of associating proteins compare across Hoxa9 and Meis1 in cell lines with and without MLL fusion proteins and how binding is altered during gene down-regulation and differentiation. Results: Consistent with earlier purifications of ENL and AF4 from 293 cells, the 90 amino acid C-terminal domain of AF9 associates with many other MLL translocation partners including Enl, Af4, Laf4, Af5q31, Ell, and Af10. This complex, termed elongation assisting proteins (EAPs), also contains the RNA polymerase II C-terminal domain kinase Cdk9/Cyclin T1/T2 (pTEFb) and the histone H3 lysine 79 methyltransferase Dot1L. Myeloid cells transformed by MLL fusions show higher levels and a broader distribution of EAP components at genes critical for leukemia. Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented. Conclusions: The findings suggest that MLL fusion proteins deregulate genes critical for leukemia by excessive recruitment and impaired dissociation of EAP from target loci.",
author = "Monroe, {Sara C.} and Jo, {Stephanie Y.} and Sanders, {Daniel S.} and Venkatesha Basrur and Elenitoba-Johnson, {Kojo S.} and Slany, {Robert K.} and Jay Hess",
year = "2011",
month = "1",
doi = "10.1016/j.exphem.2010.09.003",
language = "English (US)",
volume = "39",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia

AU - Monroe, Sara C.

AU - Jo, Stephanie Y.

AU - Sanders, Daniel S.

AU - Basrur, Venkatesha

AU - Elenitoba-Johnson, Kojo S.

AU - Slany, Robert K.

AU - Hess, Jay

PY - 2011/1

Y1 - 2011/1

N2 - Objective: The aim of this study was to better understand how mixed lineage leukemia (MLL) fusion proteins deregulate the expression of genes critical for leukemia. Materials and Methods: The transforming domain of one of the most common MLL fusion partners, AF9, was immunopurified after expression in myeloblastic M1 cells, and associating proteins were identified by mass spectrometric analysis. Chromatin immunoprecipitation followed by quantitative polymerase chain reaction was used to determine how binding of associating proteins compare across Hoxa9 and Meis1 in cell lines with and without MLL fusion proteins and how binding is altered during gene down-regulation and differentiation. Results: Consistent with earlier purifications of ENL and AF4 from 293 cells, the 90 amino acid C-terminal domain of AF9 associates with many other MLL translocation partners including Enl, Af4, Laf4, Af5q31, Ell, and Af10. This complex, termed elongation assisting proteins (EAPs), also contains the RNA polymerase II C-terminal domain kinase Cdk9/Cyclin T1/T2 (pTEFb) and the histone H3 lysine 79 methyltransferase Dot1L. Myeloid cells transformed by MLL fusions show higher levels and a broader distribution of EAP components at genes critical for leukemia. Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented. Conclusions: The findings suggest that MLL fusion proteins deregulate genes critical for leukemia by excessive recruitment and impaired dissociation of EAP from target loci.

AB - Objective: The aim of this study was to better understand how mixed lineage leukemia (MLL) fusion proteins deregulate the expression of genes critical for leukemia. Materials and Methods: The transforming domain of one of the most common MLL fusion partners, AF9, was immunopurified after expression in myeloblastic M1 cells, and associating proteins were identified by mass spectrometric analysis. Chromatin immunoprecipitation followed by quantitative polymerase chain reaction was used to determine how binding of associating proteins compare across Hoxa9 and Meis1 in cell lines with and without MLL fusion proteins and how binding is altered during gene down-regulation and differentiation. Results: Consistent with earlier purifications of ENL and AF4 from 293 cells, the 90 amino acid C-terminal domain of AF9 associates with many other MLL translocation partners including Enl, Af4, Laf4, Af5q31, Ell, and Af10. This complex, termed elongation assisting proteins (EAPs), also contains the RNA polymerase II C-terminal domain kinase Cdk9/Cyclin T1/T2 (pTEFb) and the histone H3 lysine 79 methyltransferase Dot1L. Myeloid cells transformed by MLL fusions show higher levels and a broader distribution of EAP components at genes critical for leukemia. Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented. Conclusions: The findings suggest that MLL fusion proteins deregulate genes critical for leukemia by excessive recruitment and impaired dissociation of EAP from target loci.

UR - http://www.scopus.com/inward/record.url?scp=78650205549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650205549&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2010.09.003

DO - 10.1016/j.exphem.2010.09.003

M3 - Article

C2 - 20854876

AN - SCOPUS:78650205549

VL - 39

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 1

ER -